[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Page 79900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32206]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcements (FOA) 
IP16-001, Research on the Epidemiology, Vaccine Effectiveness and 
Treatment of Influenza and Other Respiratory Viruses in Southeast Asia 
and the Western Pacific and (FOA) IP16-002, Annual Estimates of 
Influenza Vaccine Effectiveness for Preventing Medically Attended 
Laboratory-Confirmed Influenza in the United States.
    Time and Date: 10:00 a.m.-5:00 p.m., EST, February 24-25, 2016 
(Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., 
and the determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Research on the Epidemiology, Vaccine Effectiveness and Treatment 
of Influenza and Other Respiratory Viruses in Southeast Asia and the 
Western Pacific'', IP16-001 and ``Annual Estimates of Influenza Vaccine 
Effectiveness for Preventing Medically Attended Laboratory-Confirmed 
Influenza in the United States'', IP16-002.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-32206 Filed 12-22-15; 8:45 am]
BILLING CODE 4163-18-P